Cohort Study Evaluates Age at Onset and Family History as Predictors for Genetic Testing in Parkinson Disease
By
;
Crackling crust, pillowy middle. The kind of bagel that earns a second cup of coffee.
Summary
This cohort study evaluates the association between age at onset (AAO) and family history in Parkinson disease patients who carry pathogenic genetic variants. The study analyzes data from four major datasets (GP2, MDSGene, PD GENEration, and ROPAD) to determine optimal AAO thresholds for genetic testing. The findings suggest that AAO alone or combined with family history can help predict genetic forms of Parkinson disease, with performance curves showing varying sensitivity across different age thresholds. The research aims to improve genetic testing criteria and counseling for Parkinson disease patients.
Key quotes
· 3 pulledFigure 1 shows performance curves for predicting any genetic form of Parkinson disease using AAO alone or in combination with positive family history across 4 datasets.
The study evaluates the association between age at onset and family history of Parkinson disease in patients who carry pathogenic variants.
Area under the receiver operating characteristic curve (ROC) for predicting any genetic form of Parkinson disease using AAO alone or in combination with positive family history.
You might also wanna read
Experimental pill daraxonrasib extends survival in advanced pancreatic cancer patients, study finds
Researchers reported that daraxonrasib, a novel experimental pill, helped patients with advanced pancreatic cancer live longer by blocking a
GeneSkin Develops mRNA Therapy Targeting Skin Stem Cells for Rejuvenation and Hair Growth
GeneSkin is developing a novel mRNA therapy targeting basal stem cells in the skin to address a wide range of dermatological issues includin
First human trial begins for drug that could regrow missing teeth
Kyoto University Hospital has launched the first human trial of TRG-035, a drug designed to regrow teeth in adults by blocking a protein tha
Japanese researchers develop vitamin K-like compounds that may help convert brain cells into neurons
Japanese researchers have developed a new family of vitamin K-like molecules that may help immature brain cells transition into neurons. Whi
zmescience.com·1d agoInternational trial shows DNA test could help many breast cancer patients avoid chemotherapy
A new international trial presented at the American Society of Clinical Oncology conference suggests that millions of breast cancer patients
Single Infusion of Gene-Editing Therapy VERVE-102 Shows Promise for Inherited High Cholesterol
An experimental gene-editing therapy called VERVE-102, developed by Verve Therapeutics (a subsidiary of Eli Lilly), shows promise in treatin
